The Influence of Dosage Form on Aspirin Kinetics: Implications for Acute Cardiovascular Use

References

• Anti-platelet Trialists Collaboration. Collaborative overview of randomised controlled trials of antiplatelet therapy— I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Br. Med. J. 1994; 308: 81, 1061. Anti-platelet Trialists Collaboration. Collaborative overview of randomised controlled trials of antiplatelet therapy— I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Br. Med. J. 1994; 308: 81, 106
   PubMed Web of Science ®Google Scholar
• Flapan A. D. Management of patients after their first myocardial infarction. Br. Med. J. 1994; 309: 1129, 11342. Flapan A. D. Management of patients after their first myocardial infarction. Br. Med. J. 1994; 309: 1129, 1134
   PubMed Web of Science ®Google Scholar
• NHS Centre for Reviews and Dissemination. Aspirin as emergency therapy. Effectiveness Matters 1995; 1: 1, 43. NHS Centre for Reviews and Dissemination. Aspirin as emergency therapy. Effectiveness Matters 1995; 1: 1, 4
   Google Scholar
• East Norfolk Health Commission. Guidelines for Practice Procedure with a Suspected Heart Attack. 19954. East Norfolk Health Commission. Guidelines for Practice Procedure with a Suspected Heart Attack. 1995
   Google Scholar
• Weston C. F. M., Penny W. J., Julian D. G. British Heart Foundation Working Party. Guidelines for the early management of patients with MI. Br. Med. J. 1994; 308: 760, 7615. Weston C. F. M., Penny W. J., Julian D. G. British Heart Foundation Working Party. Guidelines for the early management of patients with MI. Br. Med. J. 1994; 308: 760, 761
   Google Scholar
• Pentecost G. Myocardial infarction. 1994; 816–821, Update, May6. Pentecost G. Myocardial infarction. 1994; 816–821, Update, May
   Google Scholar
• Rasmanis G., Vestequist O., Green K., Edhag O., Henriksson P. Evidence of increased platelet activation after thrombolysis in patients with acute myocardial infarction. Br. Heart J. 1992; 68: 374, 3767. Rasmanis G., Vestequist O., Green K., Edhag O., Henriksson P. Evidence of increased platelet activation after thrombolysis in patients with acute myocardial infarction. Br. Heart J. 1992; 68: 374, 376
   PubMedGoogle Scholar
• Fitzgerald D. J., Catella F., Roy L., Fitzgerald C. A. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation 1988; 77: 142, 1508. Fitzgerald D. J., Catella F., Roy L., Fitzgerald C. A. Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation 1988; 77: 142, 150
   PubMed Web of Science ®Google Scholar
• Rudd M. A., George D., Amarante P., Vaughan D. E., Loscalzo J. Temporal effects of thrombolytic agents on platelet function in vivo and their modulation by prostaglandins. Circ. Res. 1990; 67: 1175, 11819. Rudd M. A., George D., Amarante P., Vaughan D. E., Loscalzo J. Temporal effects of thrombolytic agents on platelet function in vivo and their modulation by prostaglandins. Circ. Res. 1990; 67: 1175, 1181
   PubMed Web of Science ®Google Scholar
• Reckitt, Colman. Data on file. 198310. Reckitt, Colman. Data on file. 1983
   Google Scholar
• Cochran W. G., Cox G. M. Completely randomised, randomised block or Latin square designs. Experimental Designs 2nd edn, W. A. Stewhart, S. S. Wilks. Wiley. 195711. Cochran W. G., Cox G. M. Completely randomised, randomised block or Latin square designs. Experimental Designs 2nd edn, W. A. Stewhart, S. S. Wilks. Wiley. 1957
   Google Scholar
• Hartley H. O. Some recent developments in analysis of variance. Comm. Pure App. Math. 1955; 8: 47, 7212. Hartley H. O. Some recent developments in analysis of variance. Comm. Pure App. Math. 1955; 8: 47, 72
   Web of Science ®Google Scholar
• Siegel S., Castellan N. J. Non-parametric Statistics for the Behavioural Sciences 2nd edn, C. T. Morgan. McGraw-Hill. 198813. Siegel S., Castellan N. J. Non-parametric Statistics for the Behavioural Sciences 2nd edn, C. T. Morgan. McGraw-Hill. 1988
   Google Scholar
• Muir N., Nichols J. D., Stillings M. R., Sykes J. Comparative bioavail-ability of aspirin and paracetamol following single dose administration of soluble and plain tablets. Curr. Med. Res. Opin. 1997; 13: 491, 50014. Muir N., Nichols J. D., Stillings M. R., Sykes J. Comparative bioavail-ability of aspirin and paracetamol following single dose administration of soluble and plain tablets. Curr. Med. Res. Opin. 1997; 13: 491, 500
   PubMed Web of Science ®Google Scholar
• ISIS-2 (Second International Study of Infarct Survival). Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17, 871 cases of suspected acute myocardial infarction. Lancet 1988; ii: 349, 36015. ISIS-2 (Second International Study of Infarct Survival). Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17, 871 cases of suspected acute myocardial infarction. Lancet 1988; ii: 349, 360
   Google Scholar
• Shaw P. Evidence now clear that aspirin will reduce heart and stroke deaths. Australian Doctor Weekly. 1992, August, 1916. Shaw P. Evidence now clear that aspirin will reduce heart and stroke deaths. Australian Doctor Weekly. 1992, August, 19
   Google Scholar
• Aspirin Newsletter Congress Special, J. Aumiller, 1991, Ed.17. Aspirin Newsletter Congress Special, J. Aumiller, 1991, Ed.
   Google Scholar
• Dabaghi S. F., Kamat S. G., Payne J., Markes G. F., Roberts R., Schafer A. I., Kleinman N. S. Effects of low-dose aspirin on in-vitro platelet aggregation in the early minutes after ingestion in normal subjects. Am. J. Cardiol. 1994; 74: 720, 72318. Dabaghi S. F., Kamat S. G., Payne J., Markes G. F., Roberts R., Schafer A. I., Kleinman N. S. Effects of low-dose aspirin on in-vitro platelet aggregation in the early minutes after ingestion in normal subjects. Am. J. Cardiol. 1994; 74: 720, 723
   PubMed Web of Science ®Google Scholar
• Zhang C. L., Wilson K. M., Stafford I., Bochner F., Horowitz J. D. Absorption kinetics of low dose aspirin in patients with evolving acute myocardial infarction. Drug Invest. 1994; 1: 169, 17419. Zhang C. L., Wilson K. M., Stafford I., Bochner F., Horowitz J. D. Absorption kinetics of low dose aspirin in patients with evolving acute myocardial infarction. Drug Invest. 1994; 1: 169, 174
   Google Scholar
• Elwood P. Letter. Lancet 1997; 349: 43220. Elwood P. Letter. Lancet 1997; 349: 432
   PubMedGoogle Scholar